Market Overview:
The global drospirenone market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising awareness about birth control methods, increasing prevalence of gynecological diseases, and growing demand for oral contraceptives. The global drospirenone market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into purity greater than or equal to 98% and purity greater than or equal to 99%. On the basis of application, the market is segmented into drospirenone tablets and other applications. The other applications include vaginal rings and patches. Region-wise, the global drospirenone market is divided into North America, Latin America, Europe Asia Pacific (APAC), and Middle East & Africa (MEA).
Product Definition:
drospirenone is a synthetic progestin used in combination with ethinyl estradiol for contraception and in the treatment of premenstrual dysphoric disorder.
PurityGreater than or equal to98%:
Drospirenone is a type of oral contraceptive drug. It's an anti-androgenic hormonal medication that works by decreasing the production of testosterone in men as well as women. Drospirenone has no effect on ovulation and prevents pregnancy by suppressing the release of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH) from the brain into the bloodstreams, thereby preventing implantation within the uterus.
PurityGreater than or equal to99%:
It is a white crystalline powder, which is used as an active ingredient in the formulation of oral contraceptives. It was first synthesized by accident by a team of scientists at Bayer AG in 1916. The pure form was later named as “Bayer Aspirin” and marketed commercially for over two decades before it was discovered to be an effective contraceptive agent.
Application Insights:
The other application segment dominated the global drospirenone market in terms of revenue share in 2017. This is attributed to growing use of spironolactone and its salts as a eugeroic, diuretic and anti-androgenic agent for the treatment of various disorders. The Drospirenone Tablets are used for birth control pills, acne, premenstrual syndrome (PMS), polycystic ovary syndrome (PCOS) etc. Increasing research on new applications related to Drospirenone tablets is expected to drive growth over the forecast period.
DrospIRE1/17 has been approved by U.
Regional Analysis:
Europe was the largest market for drospirenone with a revenue share of over 30% in 2017. The region is expected to continue its dominance throughout the forecast period owing to high demand from countries, such as U.K., Germany, and France among others. North America is projected to be one of the fastest-growing regional markets at an estimated CAGR of XX% from 2018 to 2030 due to increasing consumer awareness regarding Drospirenone tablets availability and safety along with growing product adoption by women for contraception purpose in this region.
Asia Pacific is anticipated to be one of the fastest-growing regions during the forecast period owing rising population coupled with changing lifestyle which increases risk of obesity leading towards health issues such as cardiovascular diseases and blood pressure disorders among others; these factors are expected drive product demand in this region over next eight years.
Growth Factors:
- Increasing awareness about contraception and birth control methods
- Rising prevalence of gynecological diseases and disorders
- Growing demand for minimally invasive procedures4. Technological advancements in drospirenone-based products5. Rising number of working women
Scope Of The Report
Report Attributes
Report Details
Report Title
Drospirenone Market Research Report
By Type
PurityGreater than or equal to98%, PurityGreater than or equal to99%
By Application
Drospirenone Tablets, Other
By Companies
Bayer Pharma Chemicals, Symbiotec, NewChem, Beijing Keyifeng Biology, DQA Pharma International, Maiden Group, Shanghai Acebright, Hubei Gedian Humanwell Pharmaceutical, Aurisco Pharmaceutical, Sterling.it, Tapi Teva, Zhejiang Xianju Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
237
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Drospirenone Market Report Segments:
The global Drospirenone market is segmented on the basis of:
Types
PurityGreater than or equal to98%, PurityGreater than or equal to99%
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Drospirenone Tablets, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bayer Pharma Chemicals
- Symbiotec
- NewChem
- Beijing Keyifeng Biology
- DQA Pharma International
- Maiden Group
- Shanghai Acebright
- Hubei Gedian Humanwell Pharmaceutical
- Aurisco Pharmaceutical
- Sterling.it
- Tapi Teva
- Zhejiang Xianju Pharmaceutical
Highlights of The Drospirenone Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- PurityGreater than or equal to98%
- PurityGreater than or equal to99%
- By Application:
- Drospirenone Tablets
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Drospirenone Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Drospirenone is a progestin hormone that is used to treat hormonal contraception. It works by preventing ovulation (the release of an egg from the ovary).
Some of the major companies in the drospirenone market are Bayer Pharma Chemicals, Symbiotec, NewChem, Beijing Keyifeng Biology, DQA Pharma International, Maiden Group, Shanghai Acebright, Hubei Gedian Humanwell Pharmaceutical, Aurisco Pharmaceutical, Sterling.it, Tapi Teva, Zhejiang Xianju Pharmaceutical.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Drospirenone Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Drospirenone Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Drospirenone Market - Supply Chain
4.5. Global Drospirenone Market Forecast
4.5.1. Drospirenone Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Drospirenone Market Size (000 Units) and Y-o-Y Growth
4.5.3. Drospirenone Market Absolute $ Opportunity
5. Global Drospirenone Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Drospirenone Market Size and Volume Forecast by Type
5.3.1. PurityGreater than or equal to98%
5.3.2. PurityGreater than or equal to99%
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Drospirenone Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Drospirenone Market Size and Volume Forecast by Application
6.3.1. Drospirenone Tablets
6.3.2. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Drospirenone Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Drospirenone Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Drospirenone Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Drospirenone Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Drospirenone Demand Share Forecast, 2019-2026
9. North America Drospirenone Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Drospirenone Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Drospirenone Market Size and Volume Forecast by Application
9.4.1. Drospirenone Tablets
9.4.2. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Drospirenone Market Size and Volume Forecast by Type
9.7.1. PurityGreater than or equal to98%
9.7.2. PurityGreater than or equal to99%
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Drospirenone Demand Share Forecast, 2019-2026
10. Latin America Drospirenone Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Drospirenone Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Drospirenone Market Size and Volume Forecast by Application
10.4.1. Drospirenone Tablets
10.4.2. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Drospirenone Market Size and Volume Forecast by Type
10.7.1. PurityGreater than or equal to98%
10.7.2. PurityGreater than or equal to99%
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Drospirenone Demand Share Forecast, 2019-2026
11. Europe Drospirenone Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Drospirenone Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Drospirenone Market Size and Volume Forecast by Application
11.4.1. Drospirenone Tablets
11.4.2. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Drospirenone Market Size and Volume Forecast by Type
11.7.1. PurityGreater than or equal to98%
11.7.2. PurityGreater than or equal to99%
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Poduct Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Drospirenone Demand Share, 2019-2026
12. Asia Pacific Drospirenone Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Drospirenone Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Drospirenone Market Size and Volume Forecast by Application
12.4.1. Drospirenone Tablets
12.4.2. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Drospirenone Market Size and Volume Forecast by Type
12.7.1. PurityGreater than or equal to98%
12.7.2. PurityGreater than or equal to99%
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Drospirenone Demand Share, 2019-2026
13. Middle East & Africa Drospirenone Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Drospirenone Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Drospirenone Market Size and Volume Forecast by Application
13.4.1. Drospirenone Tablets
13.4.2. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Drospirenone Market Size and Volume Forecast by Type
13.7.1. PurityGreater than or equal to98%
13.7.2. PurityGreater than or equal to99%
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Drospirenone Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Drospirenone Market: Market Share Analysis
14.2. Drospirenone Distributors and Customers
14.3. Drospirenone Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Bayer Pharma Chemicals
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Symbiotec
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. NewChem
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Beijing Keyifeng Biology
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. DQA Pharma International
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Maiden Group
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Shanghai Acebright
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Hubei Gedian Humanwell Pharmaceutical
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Aurisco Pharmaceutical
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Sterling.it
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Tapi Teva
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Zhejiang Xianju Pharmaceutical
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
